PBMWW Stock

Profile

Full Name:

Psyence Biomedical Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

Indexes:

Not included

Website:

http://www.psyencebiomed.com

Description:

Psyence is a biotechnology company focused on developing and commercializing psychedelic products for mental health and wellness. They aim to create innovative therapies using psilocybin and other compounds to improve patient outcomes.

Key Details

Price

$0.02

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

466.25%

Annual Debt To Equity

-0.95

Beta

-2.24

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with PBMWW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.02
PBMWW price is $0.02

Price YTD Change

+43.06%
PBMWW price is up +43.06% since January 1st

Price All-time High

$0.04
PBMWW price is currently -48.24% below its historical high of $0.04

Beta

-2.24
PBMWW beta is -2.24

200-day SMA

$0.02
PBMWW price is currently +33.77% above its 200-day simple moving average

14-day RSI

60.00
PBMWW 14-day relative strength index is 60.00

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+0%
PBMWW annual revenue is up +0% over the past 3 years

Annual Net Income 3-Year Change

+0%
PBMWW annual net profit is up +0% over the past 3 years

Annual Operating Profit

-$44.23 M
PBMWW annual operaing income is -$44.23 million

Annual Operating Profit 3-Year Change

+0%
PBMWW annual operaing income is up +0% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

466.25%
PBMWW annual return on equity is 466.25%

Annual ROA

-4518.72%
PBMWW annual return on assets is -4518.72%

Annual EBIT

-$51.11 M
PBMWW annual earnings before interest & taxes is -$51.11 million

Annual EBITDA

-$48.62 M
PBMWW annual earnings before interest, taxes, depreciation & amortization is -$48.62 million

Annual Interest Coverage Ratio

-965.34
PBMWW annual interest coverage ratio is -965.34

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

0.09
PBMWW annual current ratio is 0.09

Annual Total Assets

$1.13 M
PBMWW annual total assets is $1.13 million

Annual Current Assets

$1.13 M
PBMWW annual total current assets is $1.13 million

Annual Total Liabilities

$12.10 M
PBMWW annual total liabilities is $12.10 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

+0%
PBMWW annual cash flow from operations is up +0% over the past 3 years

Annual CFI 3-Year Change

+0%
PBMWW annual cash flow from investing activities is up +0% over the past 3 years

Annual CFF 3-Year Change

+0%
PBMWW annual cash flow from financing activities is up +0% over the past 3 years

Annual CAPEX

$5727.00
PBMWW annual capital expenditures is $5727.00

Annual CAPEX 3-Year Change

+0%
PBMWW annual capital expenditures is up +0% over the past 3 years

Annual FCF

-$2.95 M
PBMWW annual free cash flow is -$2.95 million

Annual FCF 3-Year Change

+0%
PBMWW annual free cash flow is up +0% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Psyence Biomedical Warrant?
  • What is the ticker symbol for Psyence Biomedical Warrant?
  • Does Psyence Biomedical Warrant pay dividends?
  • What sector is Psyence Biomedical Warrant in?
  • What industry is Psyence Biomedical Warrant in?
  • What country is Psyence Biomedical Warrant based in?
  • Is Psyence Biomedical Warrant in the S&P 500?
  • Is Psyence Biomedical Warrant in the NASDAQ 100?
  • Is Psyence Biomedical Warrant in the Dow Jones?
  • When does Psyence Biomedical Warrant report earnings?

What is the primary business of Psyence Biomedical Warrant?

Psyence is a biotechnology company focused on developing and commercializing psychedelic products for mental health and wellness. They aim to create innovative therapies using psilocybin and other compounds to improve patient outcomes.

What is the ticker symbol for Psyence Biomedical Warrant?

The ticker symbol for Psyence Biomedical Warrant is NASDAQ:PBMWW

Does Psyence Biomedical Warrant pay dividends?

No, Psyence Biomedical Warrant does not pay dividends

What sector is Psyence Biomedical Warrant in?

Psyence Biomedical Warrant is in the Healthcare sector

What industry is Psyence Biomedical Warrant in?

Psyence Biomedical Warrant is in the Biotechnology industry

What country is Psyence Biomedical Warrant based in?

Psyence Biomedical Warrant is headquartered in Canada

Is Psyence Biomedical Warrant in the S&P 500?

No, Psyence Biomedical Warrant is not included in the S&P 500 index

Is Psyence Biomedical Warrant in the NASDAQ 100?

No, Psyence Biomedical Warrant is not included in the NASDAQ 100 index

Is Psyence Biomedical Warrant in the Dow Jones?

No, Psyence Biomedical Warrant is not included in the Dow Jones index

When does Psyence Biomedical Warrant report earnings?

The date for Psyence Biomedical Warrant's next earnings report has not been announced yet